ภาควิชากุมารเวชศาสตร์

1.

Rungmaitree S, Werarak P, Pumpradit W, Phongsamart W, Lapphra K, Wittawatmongkol O, Durier Y, Maleesatharn A, Kuttiparambil B, Cressey TR, Hoffman RM, Chokephaibulkit K.

A pilot program of HIV pre-exposure prophylaxis in Thai youth
PLoS One. 2024. 19 (2):

2.

Santiprabhob J.; Chokephaibulkit K.; Khantee P.; Maleesatharn A.; Phonrat B.; Phongsamart W.; Lapphra K.; Wittawatmongkol O.; Rungmaitree S.; Tanchaweng S.; Maturapat S.; Lermankul W.; Tungtrongchitr R.

Corrigendum to “Adipocytokine dysregulation, abnormal glucose metabolism, and lipodystrophy in HIV-infected adolescents receiving protease inhibitors” [Cytokine 136 (2020) 155145] (Cytokine (2020) 136, (10.1016/j.cyto.2020.155145))
Cytokine. 2024. 180

3.

Chayachinda C, Watananirun K, Phatihattakorn C, Anuwutnavin S, Niyomnaitham S, Phongsamart W, Lapphra K, Wittawatmongkol O, Rungmaitree S, Jansarikit L, Boonnak K, Wongprompitak P, Senawong S, Upadhya A, Toh ZQ, Licciardi PV, Chokephaibulkit K.

Immunogenicity and reactogenicity of heterologous COVID-19 vaccination in pregnant women
Human Vaccines and Immunotherapeutics. 2023. 19 (2):

4.

Wittawatmongkol O, Bunjoungmanee P, Kosalaraksa P, Laoprasopwattana K, Boonsathorn S, Chantasrisawad N, Sudjaritruk T, Niyomnaitham S, Senawong S, Srisutthisamphan K, Quan Toh Z, Rungmaitree S, Nanthapisal S, Phanthanawiboon S, Khantee P, Techasaensiri C, Hirankarn N, Pangprasertkul S, Chokephaibulkit K.

Immunogenicity and reactogenicity of fractional, heterologous primary COVID-19 vaccination schedules with BNT162b2 boosters in 5-11-year-old Thai children: A multicenter, prospective, double-blind, randomized control trial
Vaccine. 2023. 41 (40): 5834-5840.

5.

Ruenglerdpong S.; Lapphra K.; Phongsamart W.; Wittawatmongkol O.; Rungmaitree S.; Sitthirit W.; Sinderadard K.; Chokephaibulkit K.

Characteristics of Hospital-Acquired Respiratory Syncytial Virus (RSV) Infection in Young Children Prior to the COVID-19 Outbreak
Journal of the Medical Association of Thailand. 2023. 106 (11): 1034-1040.

6.

Rungmaitree S., Thepthai C., Toh Z.Q., Musiwiraphat N., Maleesatharn A., Rermruay R., Sungkate S., Phongsamart W., Lapphra K., Wittawatmongkol O., Dharakul T., Mulholland K., Chokephaibulkit K.

Immunogenicity of a Two-Dose Human Papillomavirus Vaccine Schedule in HIV-Infected Adolescents with Immune Reconstitution
Vaccines. 2022. 10 (1):

7.

Kulsirichawaroj P., Sanmaneechai O., Wittawatmongkol O., Chokephaibulkit K.

Polyneuritis Cranialis Associated with BNT162b2 mRNA COVID-19 Vaccine in a Healthy Adolescent
Vaccines. 2022. 10 (1):

8.

Boettiger DC, An VT, Lumbiganon P, Wittawatmongkol O, Huu Truong K, Chau Do V, Van Nguyen L, Sun Ly P, Kinikar A, Ounchanum P, Puthanakit T, Kurniati N, Kumarasamy N, Kumara Wati D, Chokephaibulkit K, Jamal Mohamed TA, Sudjaritruk T, Nik Yusoff NK, Siew Fong M, Nallusamy RA, Kariminia A; TREAT Asia Pediatric HIV Observational Database.

Severe Recurrent Bacterial Pneumonia Among Children Living With HIV
Pediatr Infect Dis J. 2022.

9.

Boettiger DC, An VT, Lumbiganon P, Wittawatmongkol O, Huu Truong K, Chau Do V, Van Nguyen L, Sun Ly P, Kinikar A, Ounchanum P, Puthanakit T, Kurniati N, Kumarasamy N, Kumara Wati D, Chokephaibulkit K, Jamal Mohamed TA, Sudjaritruk T, Nik Yusoff NK, Siew Fong M, Nallusamy RA, Kariminia A; TREAT Asia Pediatric HIV Observational Database.

Severe Recurrent Bacterial Pneumonia Among Children Living With HIV
Pediatr Infect Dis J. 2022.

10.

Angkasekwinai N., Sewatanon J., Niyomnaitham S., Phumiamorn S., Sukapirom K., Sapsutthipas S., Sirijatuphat R., Wittawatmongkol O., Senawong S., Mahasirimongkol S., Trisiriwanich S., Chokephaibulkit K.

Comparison of safety and immunogenicity of CoronaVac and ChAdOx1 against the SARS-CoV-2 circulating variants of concern (Alpha, Delta, Beta) in Thai healthcare workers
Vaccine: X. 2022. 10

ภาควิชากุมารเวชศาสตร์

ผลงานที่ได้รับการตีพิมพ์

ผศ.พญ. อรศรี วิทวัสมงคล